PURPOSETo assess the safety and efficacy of the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor osimertinib as neoadjuvant therapy in patients with surgically ...

Michael R. Gordon is a national security correspondent for The Wall Street Journal. He is the author of “Degrade and Destroy: the Inside Story of the War Against the Islamic State, from Barack ...

Two centuries after his downfall, Napoleon remains both revered and controversial in France — but above all, unavoidable.

Andrew joined the Journal in 2014 to cover transportation in New York City. He came from the Los Angeles Times, where he covered Wall Street as a national business correspondent.